. Author manuscript; available in PMC: 2013 Sep 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2012 Feb 10;18(9):1368–1377. doi: 10.1016/j.bbmt.2012.02.002

Table 4.

Summary of Current Series and Published Data on Bone Marrow Transplants for CGD.

Source	Center or Group	Donor Source (# of patients)	Conditioning	Median Follow-up (months)	OS%	Engraftment %	Patients achieving high (>90%) donor chimerism
Tewari, 2012	Duke University Medical Center	R-M-BM (5)	MAC	97	100	100	100
Gozdzik, 2011	Univeristy Children’s Hospital, Cracow	R-M-BM (2), U-M-BM (3), U-MM-BM(1)	MAC (5), RIC (1)	Mean: 20	100	100	100
Soncini, 2009	UK Northern Supra Regional HSCT Unit	R-M-BM (9), U-M-BM (6), U-M-PBSC (2), U-MM-PBSC (1)	MAC(14), RIC(4)	61	88 MAC(100), RIC (50)	MAC: 100 RIC: 75	NA
Schuetz, 2009	Universtiy Hospital Ulm	R-M-BM (3), U-M-BM (6), U-M-PBSC(3)	MAC (9), RIC (3)	53	75 MAC(57), RIC (100)	MAC: 100 RIC: 66	92
Güngör, 2005	University Children’s Hospital of Zurich	M-U-BM(1), M-R-BM(2)	RIC	17	100	100	100
Seger, 2002	EBMT	R-M-BM(25), U-M-BM (2)	MAC(23), RIC (4)	24	85 MAC(92), RIC (75)	MAC: 95 RIC: 50	85
Horwitz, 2001	National Institutes of Health, Bethesda	R-M-BM(10)	RIC	17	70	80	60

R-M-BM: Related matched bone marrow, U-M-BM: Unrelated matched bone marrow; U MM-BM: Unrelated mismatched bone marrow; U-M-PBSC: Unrelated matched peripheral blood stem cells; U-MM-PBSC: Unrelated mismatched peripheral blood stem cells. MAC: Myeloablative conditioning.